139 related articles for article (PubMed ID: 38689357)
1. The effect of preoperative TSH levels on perioperative complications in patients undergoing pituitary surgery.
Kirbas G; Ozkalkanli MY; Tuzen AS
Eur J Med Res; 2024 Apr; 29(1):259. PubMed ID: 38689357
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic endonasal approach for craniopharyngioma: the importance of the relationship between pituitary stalk and tumor.
Dho YS; Kim YH; Se YB; Han DH; Kim JH; Park CK; Wang KC; Kim DG
J Neurosurg; 2018 Sep; 129(3):611-619. PubMed ID: 28960155
[TBL] [Abstract][Full Text] [Related]
4. Immediate postoperative measurement of thyroid-stimulating hormone as an early predictor of remission in thyroid-stimulating hormone-secreting pituitary adenomas.
Kim SH; Ku CR; Na M; Yoo J; Kim W; Jung IH; Kim KW; Moon JH; Kim D; Lee EJ; Kim SH; Kim EH
J Neurosurg; 2020 Mar; 134(3):794-800. PubMed ID: 32168476
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of the Craniopharyngioma Resection via Expanded Endoscopic Endonasal Transsphenoidal Approach in the Treatment of Complex Craniopharyngioma and Its Effect on Pituitary Function and Complications of Patients.
Bu X
Ann Ital Chir; 2024; 95(2):192-199. PubMed ID: 38684506
[TBL] [Abstract][Full Text] [Related]
6. Surgical management of clinically silent thyrotropin pituitary adenomas: A single center series of 20 patients.
Cyprich J; Donoho DA; Brunswick A; Hurth K; Carmichael JD; Weiss MH; Zada G
J Clin Neurosci; 2020 Jan; 71():70-75. PubMed ID: 31668712
[TBL] [Abstract][Full Text] [Related]
7. Cystic versus non-cystic silent corticotrophic adenomas: clinical and histological analysis of 62 cases after microscopic transsphenoidal surgery-a retrospective, single-center study.
Sumislawski P; Huckhagel T; Krajewski KL; Aberle J; Saeger W; Flitsch J; Rotermund R
Sci Rep; 2023 Feb; 13(1):2468. PubMed ID: 36774403
[TBL] [Abstract][Full Text] [Related]
8. Toward Shorter Hospitalization After Endoscopic Transsphenoidal Pituitary Surgery: Day-by-Day Analysis of Early Postoperative Complications and Interventions.
Shimanskaya VE; Wagenmakers MAEM; Bartels RHMA; Boogaarts HD; Grotenhuis JA; Hermus ARMM; van de Ven AC; van Lindert EJ
World Neurosurg; 2018 Mar; 111():e871-e879. PubMed ID: 29325941
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic endonasal transsphenoidal surgery in elderly patients with pituitary adenomas.
Gondim JA; Almeida JP; de Albuquerque LA; Gomes E; Schops M; Mota JI
J Neurosurg; 2015 Jul; 123(1):31-8. PubMed ID: 25839926
[TBL] [Abstract][Full Text] [Related]
10. Perianesthetic Management of Patients With Thyroid-Stimulating Hormone-Secreting Pituitary Adenomas.
Dyer MW; Gnagey A; Jones BT; Pula RD; Lanier WL; Atkinson JLD; Pasternak JJ
J Neurosurg Anesthesiol; 2017 Jul; 29(3):341-346. PubMed ID: 27322091
[TBL] [Abstract][Full Text] [Related]
11. Thyroid-stimulating hormone pituitary adenomas.
Clarke MJ; Erickson D; Castro MR; Atkinson JL
J Neurosurg; 2008 Jul; 109(1):17-22. PubMed ID: 18590428
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing the outcome of microsurgical transsphenoidal surgery for pituitary adenomas: a study on 184 patients.
Lampropoulos KI; Samonis G; Nomikos P
Hormones (Athens); 2013; 12(2):254-64. PubMed ID: 23933694
[TBL] [Abstract][Full Text] [Related]
13. Surgical Outcome and Treatment of Thyrotropin-Secreting Pituitary Tumors in a Tertiary Referral Center.
Herguido NG; Fuentes ED; Venegas-Moreno E; Maorad LB; Flores-Martinez A; Ruiz PR; Dueñas MC; Roldán F; Fajardo E; Ruiz-Valdepeñas EC; Kaen A; Martín Schrader I; Cano DA; Soto-Moreno A
World Neurosurg; 2019 Oct; 130():e634-e639. PubMed ID: 31276853
[TBL] [Abstract][Full Text] [Related]
14. Morbidity of repeat transsphenoidal surgery assessed in more than 1000 operations.
Jahangiri A; Wagner J; Han SW; Zygourakis CC; Han SJ; Tran MT; Miller LM; Tom MW; Kunwar S; Blevins LS; Aghi MK
J Neurosurg; 2014 Jul; 121(1):67-74. PubMed ID: 24834943
[TBL] [Abstract][Full Text] [Related]
15. Short-term preoperative octreotide treatment for TSH-secreting pituitary adenoma.
Fukuhara N; Horiguchi K; Nishioka H; Suzuki H; Takeshita A; Takeuchi Y; Inoshita N; Yamada S
Endocr J; 2015; 62(1):21-7. PubMed ID: 25273395
[TBL] [Abstract][Full Text] [Related]
16. Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission.
De P; Rees DA; Davies N; John R; Neal J; Mills RG; Vafidis J; Davies JS; Scanlon MF
J Clin Endocrinol Metab; 2003 Aug; 88(8):3567-72. PubMed ID: 12915637
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of craniopharyngiomas: endocrinological results.
Honegger J; Buchfelder M; Fahlbusch R
J Neurosurg; 1999 Feb; 90(2):251-7. PubMed ID: 9950495
[TBL] [Abstract][Full Text] [Related]
18. Pseudocapsular resection in elderly patients with non-functioning pituitary adenoma.
Kinoshita Y; Taguchi A; Tominaga A; Arita K; Yamasaki F
Clin Neurol Neurosurg; 2021 Nov; 210():106997. PubMed ID: 34741976
[TBL] [Abstract][Full Text] [Related]
19. Clinical and morphological characteristics, diagnostic criteria, and outcomes of surgical treatment of TSH-secreting pituitary adenomas.
Astaf'eva LI; Kadashev BA; Shishkina LV; Kalinin PL; Fomichev DV; Kutin MA; Aref'eva IA; Dzeranova LK; Sidneva YG; Klochkova IS; Rotin DL
Zh Vopr Neirokhir Im N N Burdenko; 2016; 80(6):24-35. PubMed ID: 28139570
[TBL] [Abstract][Full Text] [Related]
20. Prediction of postoperative diabetes insipidus using morphological hyperintensity patterns in the pituitary stalk on magnetic resonance imaging after transsphenoidal surgery for sellar tumors.
Hayashi Y; Kita D; Watanabe T; Fukui I; Sasagawa Y; Oishi M; Tachibana O; Ueda F; Nakada M
Pituitary; 2016 Dec; 19(6):552-559. PubMed ID: 27586498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
